Inhibition of T-cell reactivity to myasthenogenic epitopes of the human acetylcholine receptor by synthetic analogs
about
The concept of specific immune treatment against autoimmune diseases.Suppression of myasthenogenic responses of a T cell line by a dual altered peptide ligand by induction of CD4+CD25+ regulatory cellsInduction of dominant transplantation tolerance by an altered peptide ligand of the male antigen Dby.Peptide-based immunotherapy of autoimmunity: a path of puzzles, paradoxes and possibilities.Oral administration of a dual analog of two myasthenogenic T cell epitopes down-regulates experimental autoimmune myasthenia gravis in miceTherapeutic vaccines in autoimmunity.Autoreactive T Cells from Patients with Myasthenia Gravis Are Characterized by Elevated IL-17, IFN-γ, and GM-CSF and Diminished IL-10 Production.A peptide composed of tandem analogs of two myasthenogenic T cell epitopes interferes with specific autoimmune responses.Modulation of murine systemic lupus erythematosus with peptides based on complementarity determining regions of a pathogenic anti-DNA monoclonal antibody.Altered peptide ligands act as partial agonists by inhibiting phospholipase C activity induced by myasthenogenic T cell epitopesPeptide analogs to pathogenic epitopes of the human acetylcholine receptor alpha subunit as potential modulators of myasthenia gravis.Taming the TCR: antigen-specific immunotherapeutic agents for autoimmune diseases.Inhibition of naïve class I-restricted T cells by altered peptide ligands
P2860
Q33805856-330C08A1-16A6-4F8D-842A-6E91DFED2C8CQ33900697-FFA21A6E-AB2F-4A32-A47C-E6B1092C4C92Q34380578-33C92EBE-B785-422C-ADB9-010C3BADF228Q34567730-0D56A663-5A97-45CB-993C-8CD544608AC3Q35050420-25ECBD0D-E2F9-483B-A94C-76E308690ECAQ35861944-28997D0C-A4E3-4A29-BA5C-2559128699A7Q35908826-D21B521B-B2F8-4CDC-825D-B5ACB48E357DQ36083197-3E9F59C9-C1B5-4DA5-9353-0614517697D9Q36141585-81B515BD-FEAA-47C5-9C1D-2972E5E48144Q36733897-1DC08C33-0CF4-47B7-A302-26AFDD67AA2DQ37641622-ED05EF44-B80C-47E1-B63F-2F537198DC28Q38477340-F3F00AD3-CEDF-4BF2-A446-76568A45E53CQ57227993-3B7F0B8A-B028-4BF2-A606-B94D67FDDDCD
P2860
Inhibition of T-cell reactivity to myasthenogenic epitopes of the human acetylcholine receptor by synthetic analogs
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Inhibition of T-cell reactivit ...... receptor by synthetic analogs
@ast
Inhibition of T-cell reactivit ...... receptor by synthetic analogs
@en
type
label
Inhibition of T-cell reactivit ...... receptor by synthetic analogs
@ast
Inhibition of T-cell reactivit ...... receptor by synthetic analogs
@en
prefLabel
Inhibition of T-cell reactivit ...... receptor by synthetic analogs
@ast
Inhibition of T-cell reactivit ...... receptor by synthetic analogs
@en
P2093
P2860
P356
P1476
Inhibition of T-cell reactivit ...... receptor by synthetic analogs
@en
P2093
P2860
P304
P356
10.1073/PNAS.90.15.7000
P407
P577
1993-08-01T00:00:00Z